LCTL
geneOn this page
Also known as KLPHFLJ33279KLG
Summary
LCTL (lactase like, HGNC:15583) is a protein-coding gene on chromosome 15q22.31, encoding Lactase-like protein (Q6UWM7). Plays a role in formation of the lens suture in the eye, which is important for normal optical properties of the lens.
This gene encodes a member of family 1 glycosidases. Glycosidases are enzymes that hydrolyze glycosidic bonds and are classified into families based on primary amino acid sequence. Most members of family 1 have two conserved glutamic acid residues, which are required for enzymatic activity. The mouse ortholog of this protein has been characterized and has a domain structure of an N-terminal signal peptide, glycosidase domain, transmembrane domain, and a short cytoplasmic tail. It lacks one of the conserved glutamic acid residues important for catalysis, and its function remains to be determined (PMID: 12084582). Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 197021 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 123 total — 1 pathogenic
- MANE Select transcript:
NM_207338
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15583 |
| Approved symbol | LCTL |
| Name | lactase like |
| Location | 15q22.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KLPH, FLJ33279, KLG |
| Ensembl gene | ENSG00000188501 |
| Ensembl biotype | protein_coding |
| OMIM | 617060 |
| Entrez | 197021 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 4 protein_coding, 2 protein_coding_CDS_not_defined, 2 nonsense_mediated_decay
ENST00000341509, ENST00000537670, ENST00000562179, ENST00000563438, ENST00000565875, ENST00000695544, ENST00000695545, ENST00000695565
RefSeq mRNA: 4 — MANE Select: NM_207338
NM_001278562, NM_001394632, NM_001394633, NM_207338
CCDS: CCDS10220, CCDS61678
Canonical transcript exons
ENST00000695545 — 14 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001369307 | 66561006 | 66561101 |
| ENSE00001373612 | 66550041 | 66550104 |
| ENSE00001382135 | 66551662 | 66551861 |
| ENSE00001390525 | 66557982 | 66558036 |
| ENSE00003463942 | 66564676 | 66564839 |
| ENSE00003524851 | 66552984 | 66553258 |
| ENSE00003584590 | 66561187 | 66561315 |
| ENSE00003612274 | 66552043 | 66552169 |
| ENSE00003634823 | 66563516 | 66563625 |
| ENSE00003646039 | 66557722 | 66557883 |
| ENSE00003688068 | 66563911 | 66563998 |
| ENSE00003964231 | 66547532 | 66548605 |
| ENSE00003964234 | 66565857 | 66565998 |
| ENSE00003964235 | 66565248 | 66565387 |
Expression profiles
Bgee: expression breadth ubiquitous, 123 present calls, max score 83.22.
FANTOM5 (CAGE): breadth broad, TPM avg 1.0996 / max 54.2742, expressed in 480 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 150606 | 0.8365 | 425 |
| 150605 | 0.1427 | 81 |
| 150604 | 0.1204 | 59 |
Top tissues by expression
220 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 83.22 | gold quality |
| tibial nerve | UBERON:0001323 | 82.28 | gold quality |
| buccal mucosa cell | CL:0002336 | 80.25 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.67 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 73.77 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 72.10 | gold quality |
| spinal cord | UBERON:0002240 | 70.75 | gold quality |
| stromal cell of endometrium | CL:0002255 | 61.36 | gold quality |
| caudate nucleus | UBERON:0001873 | 61.16 | gold quality |
| nucleus accumbens | UBERON:0001882 | 59.53 | gold quality |
| amygdala | UBERON:0001876 | 59.11 | gold quality |
| ventricular zone | UBERON:0003053 | 57.98 | gold quality |
| putamen | UBERON:0001874 | 57.93 | gold quality |
| substantia nigra | UBERON:0002038 | 57.08 | gold quality |
| tibia | UBERON:0000979 | 55.59 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 55.08 | gold quality |
| midbrain | UBERON:0001891 | 55.02 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 53.94 | gold quality |
| prefrontal cortex | UBERON:0000451 | 53.46 | gold quality |
| hypothalamus | UBERON:0001898 | 52.60 | gold quality |
| ganglionic eminence | UBERON:0004023 | 52.34 | gold quality |
| temporal lobe | UBERON:0001871 | 50.94 | gold quality |
| forebrain | UBERON:0001890 | 50.78 | gold quality |
| Ammon’s horn | UBERON:0001954 | 50.46 | gold quality |
| neocortex | UBERON:0001950 | 50.42 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 49.81 | gold quality |
| frontal cortex | UBERON:0001870 | 49.75 | gold quality |
| brain | UBERON:0000955 | 49.73 | gold quality |
| right frontal lobe | UBERON:0002810 | 49.73 | gold quality |
| cerebral cortex | UBERON:0000956 | 49.40 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-2983 | no | 7.96 |
| E-ANND-3 | no | 3.68 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
75 targeting LCTL, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548BB-5P | 99.94 | 71.27 | 3509 |
| HSA-MIR-548C-5P | 99.94 | 71.24 | 3488 |
Literature-anchored findings (GeneRIF, showing 1)
- The authors identified and cloned the mouse lactase-like gene (also known as Lctl, Klph). It is a member of the family 1 glycosidases but lacks one of the conserved glutamic acid residues important for catalysis. Its function remains to be determined. (PMID:12084582)
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | lctlb | ENSDARG00000016337 |
| danio_rerio | lctla | ENSDARG00000036139 |
| mus_musculus | Lctl | ENSMUSG00000032401 |
| rattus_norvegicus | Lctl | ENSRNOG00000009193 |
| drosophila_melanogaster | CG9701 | FBGN0036659 |
| caenorhabditis_elegans | WBGENE00016848 | |
| caenorhabditis_elegans | WBGENE00017103 |
Paralogs (4): LCT (ENSG00000115850), KL (ENSG00000133116), KLB (ENSG00000134962), GBA3 (ENSG00000249948)
Protein
Protein identifiers
Lactase-like protein — Q6UWM7 (reviewed: Q6UWM7)
Alternative names: Klotho/lactase-phlorizin hydrolase-related protein
All UniProt accessions (4): A0A8Q3SI25, A0A8Q3WKK9, H3BQI3, Q6UWM7
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in formation of the lens suture in the eye, which is important for normal optical properties of the lens.
Subunit / interactions. May form dimers.
Subcellular location. Endoplasmic reticulum membrane.
Similarity. Belongs to the glycosyl hydrolase 1 family. Klotho subfamily.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6UWM7-1 | 1 | yes |
| Q6UWM7-2 | 2 |
RefSeq proteins (4): NP_001265491, NP_001381561, NP_001381562, NP_997221* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001360 | Glyco_hydro_1 | Family |
| IPR017853 | GH_hydrolase_sf | Homologous_superfamily |
| IPR018120 | Glyco_hydro_1_AS | Active_site |
| IPR033132 | GH_1_N_CS | Conserved_site |
Pfam: PF00232
UniProt features (11 total): glycosylation site 3, sequence variant 2, topological domain 2, signal peptide 1, chain 1, transmembrane region 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6UWM7-F1 | 92.71 | 0.85 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (3): 80, 171, 245
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 66 (showing top):
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, GOBP_ANIMAL_ORGAN_MORPHOGENESIS, GOBP_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS, TGCTGAY_UNKNOWN, GOBP_CARBOHYDRATE_METABOLIC_PROCESS, DODD_NASOPHARYNGEAL_CARCINOMA_UP, GOBP_SENSORY_PERCEPTION, GOBP_SENSORY_ORGAN_DEVELOPMENT, GOBP_SENSORY_ORGAN_MORPHOGENESIS, GOBP_LENS_MORPHOGENESIS_IN_CAMERA_TYPE_EYE, GOBP_CAMERA_TYPE_EYE_MORPHOGENESIS, NFE2_01, GOBP_LENS_DEVELOPMENT_IN_CAMERA_TYPE_EYE, GOBP_EYE_MORPHOGENESIS, GOCC_APICAL_PART_OF_CELL
GO Biological Process (3): lens morphogenesis in camera-type eye (GO:0002089), carbohydrate metabolic process (GO:0005975), visual perception (GO:0007601)
GO Molecular Function (1): hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)
GO Cellular Component (4): endoplasmic reticulum membrane (GO:0005789), brush border (GO:0005903), endoplasmic reticulum (GO:0005783), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| lens development in camera-type eye | 1 |
| anatomical structure morphogenesis | 1 |
| camera-type eye morphogenesis | 1 |
| primary metabolic process | 1 |
| sensory perception of light stimulus | 1 |
| hydrolase activity, acting on glycosyl bonds | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| microvillus | 1 |
| apical part of cell | 1 |
| cluster of actin-based cell projections | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
658 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LCTL | FGF23 | Q9GZV9 | 827 |
| LCTL | TRPV5 | Q9NQA5 | 739 |
| LCTL | GINM1 | Q9NU53 | 572 |
| LCTL | FGFR1 | P11362 | 520 |
| LCTL | SNAPC5 | O75971 | 518 |
| LCTL | SCYL1 | Q96KG9 | 498 |
| LCTL | SMIM12 | Q96EX1 | 490 |
| LCTL | MNMIP1 | A4FU49 | 479 |
| LCTL | ADAM10 | O14672 | 476 |
| LCTL | ADAM17 | P78536 | 460 |
| LCTL | SLC22A4 | Q9H015 | 439 |
| LCTL | SHISA4 | Q96DD7 | 438 |
| LCTL | PIP4K2C | Q8TBX8 | 437 |
| LCTL | S100A5 | P33763 | 431 |
| LCTL | LGSN | Q5TDP6 | 427 |
IntAct
17 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EIF4ENIF1 | MCRIP1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| EIF4ENIF1 | PABPC1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ITGA8 | SUSD5 | psi-mi:“MI:0914”(association) | 0.350 |
| LCTL | SUSD5 | psi-mi:“MI:0914”(association) | 0.350 |
| AKT1 | LCTL | psi-mi:“MI:2364”(proximity) | 0.270 |
| FBXW7 | LCTL | psi-mi:“MI:2364”(proximity) | 0.270 |
| SMAD4 | LCTL | psi-mi:“MI:2364”(proximity) | 0.270 |
| SPOP | LCTL | psi-mi:“MI:2364”(proximity) | 0.270 |
| LCTL | SPOP | psi-mi:“MI:2364”(proximity) | 0.270 |
| LCTL | BRAF | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (25): LCTL (Affinity Capture-MS), LCTL (Affinity Capture-MS), SLC25A46 (Affinity Capture-MS), LGALS1 (Affinity Capture-MS), SFXN5 (Affinity Capture-MS), USP22 (Affinity Capture-MS), GHITM (Affinity Capture-MS), SUSD5 (Affinity Capture-MS), CYP2S1 (Affinity Capture-MS), LEMD3 (Affinity Capture-MS), FAM69A (Affinity Capture-MS), NETO2 (Affinity Capture-MS), ZDHHC17 (Affinity Capture-MS), NUS1 (Affinity Capture-MS), DHRS7 (Affinity Capture-MS)
ESM2 similar proteins: B2GUY2, O18835, O35082, P04062, P17405, P17439, P18424, P22413, P57110, P58242, P82450, Q04519, Q0VD19, Q13219, Q2KHZ8, Q3MI05, Q566E5, Q5R8E3, Q5RFU0, Q5VSG8, Q6P1J0, Q6UWM7, Q6YGZ1, Q70KH2, Q71RP1, Q86Z14, Q8BYL4, Q8K1F9, Q8K3F2, Q8N119, Q8R2R1, Q8R4K8, Q8WP17, Q90YK5, Q92485, Q96JK4, Q99N32, Q9BDT0, Q9DGD1, Q9HAT2
Diamond homologs: A2SY66, A3BMZ5, A3C053, A3RF67, B3H5Q1, B6ZKM3, B6ZKM4, B6ZKM5, B6ZKN1, B7F7K7, B7F8N7, B8AVF0, B9FHH2, B9K7M5, D5MTF8, E3W9M3, O48779, O64879, O64882, O64883, O65458, O80689, O80690, P26204, P26205, P29736, P49235, Q03506, Q08638, Q0DA21, Q0DIT2, Q0J0G1, Q0J0G2, Q0J0N4, Q1XH04, Q1XH05, Q1XIR9, Q25BW4, Q25BW5, Q2QSR8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
123 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 105 |
| Likely benign | 10 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 590960 | GRCh37/hg19 15q22.31-22.33(chr15:66825594-67400490) | Pathogenic |
SpliceAI
1808 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:66548335:A:AG | acceptor_gain | 1.0000 |
| 15:66561182:CTTA:C | donor_loss | 1.0000 |
| 15:66561183:TTAC:T | donor_loss | 1.0000 |
| 15:66561184:TA:T | donor_loss | 1.0000 |
| 15:66561185:A:AC | donor_gain | 1.0000 |
| 15:66561185:A:C | donor_loss | 1.0000 |
| 15:66561185:AC:A | donor_gain | 1.0000 |
| 15:66561186:C:CC | donor_gain | 1.0000 |
| 15:66561186:CC:C | donor_gain | 1.0000 |
| 15:66561311:AGCAG:A | acceptor_gain | 1.0000 |
| 15:66561312:GCAG:G | acceptor_gain | 1.0000 |
| 15:66561313:CAG:C | acceptor_gain | 1.0000 |
| 15:66561313:CAGC:C | acceptor_gain | 1.0000 |
| 15:66561314:AG:A | acceptor_gain | 1.0000 |
| 15:66561316:C:CC | acceptor_gain | 1.0000 |
| 15:66561323:C:CT | acceptor_gain | 1.0000 |
| 15:66561325:C:CT | acceptor_gain | 1.0000 |
| 15:66563510:CCTCA:C | donor_loss | 1.0000 |
| 15:66563511:CTCA:C | donor_loss | 1.0000 |
| 15:66563512:TCA:T | donor_loss | 1.0000 |
| 15:66563513:CACCT:C | donor_loss | 1.0000 |
| 15:66563621:CTCGG:C | acceptor_gain | 1.0000 |
| 15:66563623:CGG:C | acceptor_gain | 1.0000 |
| 15:66563624:GG:G | acceptor_gain | 1.0000 |
| 15:66563624:GGC:G | acceptor_loss | 1.0000 |
| 15:66563625:GC:G | acceptor_loss | 1.0000 |
| 15:66563626:C:CC | acceptor_gain | 1.0000 |
| 15:66563629:CAGG:C | acceptor_gain | 1.0000 |
| 15:66563632:G:C | acceptor_gain | 1.0000 |
| 15:66563632:G:GC | acceptor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000012831 (15:66552667 C>A,T), RS1000356251 (15:66553653 G>A,T), RS1000478294 (15:66547148 T>A), RS1000815299 (15:66548784 A>C,G), RS1000831007 (15:66565477 G>A), RS1000920123 (15:66555895 T>C), RS1000981258 (15:66564992 C>G), RS1001150206 (15:66550163 A>G), RS1001223218 (15:66566596 G>A), RS1001317896 (15:66562384 C>T), RS1001333090 (15:66567431 G>A), RS1001602093 (15:66562564 G>A,C), RS1001629308 (15:66555354 G>A), RS1001721300 (15:66561437 T>C), RS1001848196 (15:66550241 G>A)
Disease associations
OMIM: gene MIM:617060 | disease phenotypes: MIM:109730
GenCC curated gene-disease
Mondo (1): aortic valve disease 1 (MONDO:0024523)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006957_4 | Severe aortic features in Marfan syndrome | 8.000000e-06 |
| GCST009391_1596 | Metabolite levels | 8.000000e-06 |
| GCST010002_173 | Refractive error | 2.000000e-12 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010376 | phosphatidylcholine 34:2 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, increases methylation | 6 |
| trichostatin A | affects cotreatment, decreases expression | 3 |
| entinostat | decreases expression, affects cotreatment | 2 |
| belinostat | decreases expression, affects cotreatment | 2 |
| Panobinostat | affects cotreatment, decreases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| methylmercuric chloride | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| tebuconazole | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | decreases expression, affects cotreatment | 1 |
| jinfukang | increases expression | 1 |
| Amiodarone | increases expression | 1 |
| Arbutin | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Triclosan | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): aortic valve disease 1, thoracic aortic aneurysm